Mexiletine and Propafenone interaction

Mexiletine and Propafenone: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Propafenone (propafenone hydrochloride) label · effective 2026-01-29

Major

• The applicability of the CAST results to other populations (e.g., those without recent myocardial infarction) or other antiarrhythmic drugs is uncertain, but at present, it is prudent to consider any IC antiarrhythmic to have a significant proarrhythmic risk in patients with structural heart disease.

Boxed warningby drug classView label on DailyMed
Major

• Avoid use with other antiarrhythmic agents or drugs that prolong the QT interval.

Warnings and precautionsby drug classView label on DailyMed
Minor

Concurrent use of propafenone with other antiarrhythmic agents has not been well studied.

Warnings and precautionsby drug classView label on DailyMed

From the Mexiletine (Mexiletine Hydrochloride) label · effective 2026-01-15

Major

Considering the known proarrhythmic properties of mexiletine and the lack of evidence of improved survival for any antiarrhythmic drug in patients without life-threatening arrhythmias, the use of mexiletine as well as other antiarrhythmic agents should be reserved for patients with life-threatening ventricular arrhythmia.

Boxed warningby drug classView label on DailyMed
Minor

In this crossover steady state study, the pharmacokinetics of propafenone were unaffected in either phenotype by the coadministration of mexiletine.

Drug interactionsnames PropafenoneView label on DailyMed
Minor

Addition of mexiletine to propafenone did not lead to further electrocardiographic parameters changes of QRS, QT C , RR, and PR intervals than propafenone alone.

Drug interactionsnames PropafenoneView label on DailyMed
No interaction

In another formal study (n = 8 extensive and n = 7 poor metabolizers of CYP2D6), coadministration of propafenone did not alter the kinetics of mexiletine in the poor CYP2D6 metabolizer group.

Drug interactionsnames PropafenoneView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.